Key result
Advanced age in chronic ischemic heart disease linked to ~12 percentage points lower myocardial muscle area.
Why the study?
Autopsy-based morphometric evidence of age-related myocardial and vascular remodelling in chronic ischaemic heart disease across narrowly defined age groups remains limited.
Observational (n=104)
This autopsy-based morphometric study demonstrates significant progressive age-related myocardial fibrosis, vascular remodelling, and reduction in cardiomyocyte area in individuals with chronic ischaemic heart disease.
May inform age-stratified mechanistic studies in chronic IHD; hypothesis-generating and should not yet change practice.
Background: Age-related myocardial and vascular remodelling is recognised, but autopsy-based morphometric evidence across narrowly defined age groups in chronic ischaemic heart disease remains limited. Aim: To characterise pathomorphological and morphometric changes in myocardial structures across age groups among individuals who died from atherosclerotic cardiosclerosis. Methods: Left ventricular and interventricular septal tissue from 104 autopsy cases was examined across five age brackets: 51–55, 56–59, 60–65, 66–70, and over 70 years. Histological sections were stained with haematoxylin-eosin, Van Gieson’s, and Weigert’s methods, and morphometry was performed using Avtandilov’s point-counting method. Results: Dystrophic, necrobiotic, fibrotic, and oedematous changes became more pronounced with age. Mean cardiomyocyte size was 26.7±0.07 μm in the younger group, 28.6±0.08 μm in the middle-aged group, and 21.7±0.02 μm in the elderly group. Muscle-tissue area declined from 63.7% at 51–55 years to 52.2% in those over 70 years, while fibrous-tissue area peaked at 39.3% at 60–65 years. Intramyocardial vessel-wall area increased from 9.8±0.25% to 12.7±0.23%, whereas vascular lumen area decreased from 5.2±0.19% to 4.2±0.20%. Conclusion: The findings demonstrate age-associated differences in cardiomyocyte dimensions, fibrous-tissue representation, and intramyocardial vascular remodelling within chronic ischaemic heart disease. These results should be interpreted within this disease-only autopsy population because no non-ischaemic control group was included.
No takes yet. Share an insight, caveat, or question.
Файзуллoевич et al. (2026) conducted an observational in Chronic ischemic heart disease due to atherosclerotic cardiosclerosis (n=104). Advanced age vs. Younger age (51-55 years) was evaluated on Pathomorphological and morphometric changes in myocardial structures. Advanced age in patients who died from chronic ischemic heart disease was associated with decreased muscle-tissue area (from 63.7% at 51-55 years to 52.2% over 70 years).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: